In BRCA1-deficient triple-negative breast cancer (TNBC) cells, PARP3 inhibition exacerbates centrosome amplification and genome instability via limitation of Rictor protein level by ubiquitination, thus efficiently represses oncogenic Rictor/mTORC2 signaling 45. This evidence concerns the gene BRCA1 and triple-negative breast carcinoma.